Reported 12 months ago
LB.1 is a new COVID-19 subvariant making up 17.5% of new cases in the U.S., with similar symptoms to previous variants and no evidence of increased severity. The variant may contribute to a summer surge, but current rapid tests, treatments like Paxlovid, and upcoming updated vaccines are expected to provide sufficient protection. Health experts emphasize the importance of continuous vigilance, vaccination, and adaptive health strategies in managing the impact of COVID-19.
Source: YAHOO